InvestorPlace - Stock Market News, Stock Advice & Trading Tips Moderna (MRNA) stock has shed roughly 90% of its value since its 2021 peak.
If you are wondering whether Moderna's current share price reflects its true potential, or if the market is still anchored to ...
StockStory.org on MSN
Moderna’s Q4 earnings call: Our top 5 analyst questions
Moderna’s fourth quarter results were received positively by the market, reflecting a combination of better-than-expected ...
FDA issues a Refusal to File letter to Moderna (NasdaqGS:MRNA) for its influenza vaccine candidate mRNA-1010. The decision centers on the choice of clinical trial comparator, not on safety or efficacy ...
Moderna (MRNA) came out with a quarterly loss of $2.11 per share versus the Zacks Consensus Estimate of a loss of $2.6. This compares to a loss of $2.5 per share a year ago. These figures are adjusted ...
StockStory.org on MSN
Moderna, Vertex Pharmaceuticals, Integra LifeSciences, Baxter, and Molina Healthcare shares are soaring, what you need to know
What Happened? A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price ...
Moderna (MRNA) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $2.15. This compares to earnings of $0.03 per share a year ago. These figures are ...
CAMBRIDGE, MA / ACCESS Newswire / January 26, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 13, 2026 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results